Description

Receptor pharmacology data for a phytocannabinoid at targets implicated in seizure modulation are presented. Binding affinity and functional selectivity vary across receptor subtypes.

Figure 300

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 300: Receptor pharmacology data for a phytocannabinoid at targets implicated in seizure modulation are presented. Binding affinity and functional selectivity vary across receptor subtypes.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Receptor pharmacology data for a phytocannabinoid at targets implicated in seizure modulation are presented. Binding affinity and functional selectivity vary across receptor subtypes." />
  <figcaption>Figure 300. Receptor pharmacology data for a phytocannabinoid at targets implicated in seizure modulation are presented. Binding affinity and functional selectivity vary across receptor subtypes.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Related Evidence

CBD for Insomnia

Grade A · 103 studies